Valanx BioTech develop targeted therapy technology to combat cancer – RebelBio Review
Austrian spin-out Valanx BioTech was founded by Michael Lukesch and Partik Fladischer and may be set to revolutionise the cancer treatment through a new targete...
Monoclonal antibodies